» Articles » PMID: 38748243

Assessment of Pulmonary Physiological Changes Caused by Aging, Cigarette Smoking, and COPD with Hyperpolarized Xe Magnetic Resonance

Overview
Journal Eur Radiol
Specialty Radiology
Date 2024 May 15
PMID 38748243
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To comprehensively assess the impact of aging, cigarette smoking, and chronic obstructive pulmonary disease (COPD) on pulmonary physiology using Xe MR.

Methods: A total of 90 subjects were categorized into four groups, including healthy young (HY, n = 20), age-matched control (AMC, n = 20), asymptomatic smokers (AS, n = 28), and COPD patients (n = 22). Xe MR was utilized to obtain pulmonary physiological parameters, including ventilation defect percent (VDP), alveolar sleeve depth (h), apparent diffusion coefficient (ADC), total septal wall thickness (d), and ratio of xenon signal from red blood cells and interstitial tissue/plasma (RBC/TP).

Results: Significant differences were found in the measured VDP (p = 0.035), h (p = 0.003), and RBC/TP (p = 0.003) between the HY and AMC groups. Compared with the AMC group, higher VDP (p = 0.020) and d (p = 0.048) were found in the AS group; higher VDP (p < 0.001), d (p < 0.001) and ADC (p < 0.001), and lower h (p < 0.001) and RBC/TP (p < 0.001) were found in the COPD group. Moreover, significant differences were also found in the measured VDP (p < 0.001), h (p < 0.001), ADC (p < 0.001), d (p = 0.008), and RBC/TP (p = 0.032) between the AS and COPD groups.

Conclusion: Our findings indicate that pulmonary structure and functional changes caused by aging, cigarette smoking, and COPD are various, and show a progressive deterioration with the accumulation of these risk factors, including cigarette smoking and COPD.

Clinical Relevance Statement: Pathophysiological changes can be difficult to comprehensively understand due to limitations in common techniques and multifactorial etiologies. Xe MRI can demonstrate structural and functional changes caused by several common factors and can be used to better understand patients' underlying pathology.

Key Points: Standard techniques for assessing pathophysiological lung function changes, spirometry, and chest CT come with limitations. Xe MR demonstrated progressive deterioration with accumulation of the investigated risk factors, without these limitations. Xe MR can assess lung changes related to these risk factors to stage and evaluate the etiology of the disease.

Citing Articles

Hyperpolarized Xenon-129 MRI: Narrative Review of Clinical Studies, Testing, and Implementation of Advanced Pulmonary In Vivo Imaging and Its Diagnostic Applications.

MacLeod J, Khan H, Franklin A, Myc L, Shim Y Diagnostics (Basel). 2025; 15(4).

PMID: 40002625 PMC: 11854573. DOI: 10.3390/diagnostics15040474.


A thermally polarized, dissolved-phase Xe phantom for quality-control and multisite comparisons of gas-exchange imaging.

Willmering M, Albert B, Plummer J, Greer J, Walkup L, Lindquist D J Magn Reson. 2025; 371:107829.

PMID: 39809025 PMC: 11807756. DOI: 10.1016/j.jmr.2025.107829.


Direct imaging of pulmonary gas exchange with hyperpolarized xenon MRI.

Li H, Li H, Zhang M, Huang C, Zhou X Innovation (Camb). 2024; 5(6):100720.

PMID: 39529951 PMC: 11551488. DOI: 10.1016/j.xinn.2024.100720.


Same-Day Repeatability and 28-Day Reproducibility of Xenon MRI Ventilation in Children With Cystic Fibrosis in a Multi-Site Trial.

Walkup L, Roach D, Plummer J, Willmering M, Zanette B, Santyr G J Magn Reson Imaging. 2024; 61(4):1664-1674.

PMID: 39257323 PMC: 11896927. DOI: 10.1002/jmri.29605.

References
1.
Safiri S, Carson-Chahhoud K, Noori M, Nejadghaderi S, Sullman M, Heris J . Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. BMJ. 2022; 378:e069679. PMC: 9326843. DOI: 10.1136/bmj-2021-069679. View

2.
Feenstra T, van Genugten M, Hoogenveen R, Wouters E, Rutten-van Molken M . The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med. 2001; 164(4):590-6. DOI: 10.1164/ajrccm.164.4.2003167. View

3.
MacNee W . Is Chronic Obstructive Pulmonary Disease an Accelerated Aging Disease?. Ann Am Thorac Soc. 2016; 13 Suppl 5:S429-S437. DOI: 10.1513/AnnalsATS.201602-124AW. View

4.
Tuder R . Aging and cigarette smoke: fueling the fire. Am J Respir Crit Care Med. 2006; 174(5):490-1. DOI: 10.1164/rccm.200607-924ED. View

5.
Poels P, Schermer T, van Weel C, Calverley P . Spirometry in chronic obstructive pulmonary disease. BMJ. 2006; 333(7574):870-1. PMC: 1626302. DOI: 10.1136/bmj.38987.478727.80. View